The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

Venture Capital for Physicians

9 Responses

1. Hope Rachel Hetico RN MHA, on August 3, 2011 at 12:38 PM said:

   VC Investments In Health IT Jump 27%

   While overall investments in healthcare declined, venture capitalists are increasing their bets on health IT.

   http://money.msn.com/investment-advice/article.aspx?post=ddc84231-cdbe-488e-9e70-f2c283557318

   Hope Rachel Hetico RN MHA

   LikeLike
2. Dr. David Edward Marcinko MBA, on August 4, 2011 at 9:43 PM said:

   About Health Care Investment Visions ®

   Health Care Investment Visions® is a venture management, funding and governance firm driven by deep industry knowledge and proven management principles.

   Their focus is solely on corporate and individual entrepreneurship in the health care information technology sector. They advance innovation by managing context-determined risk using an adaptive management method, and govern by influencing resources along the course of action.

   Check em’ out: http://www.hciv.com/about/index.html

   Dr. David Edward Marcinko MBA

   LikeLike
3. Dr. David Edward Marcinko MBA CMP™, on June 13, 2015 at 11:02 AM said:

   This M&A Boom Looks Different Than 2007

   Corporate mergers and acquisitions are at the highest levels since 2007.

   http://wealthmanagement.com/fixed-income/ma-boom-looks-different-2007?NL=WM-10&Issue=WM-10_20150613_WM-10_708&sfvc4enews=42&cl=article_3&utm_rid=CPG09000002702210&utm_campaign=2982&utm_medium=email&elq2=fbfb6a434f2443d5a618421d13daa420

   Is this the top of the cycle?

   Dr. David Edward Marcinko MBA CMP™

   LikeLike
4. Dr. David Marcinko MBA, on January 21, 2016 at 5:11 PM said:

   Is Health care Ripe for Disintermediation?

   Ashton KutcherWhat do Ashton Kutcher, Donald Trump and Travis Kalanick have in common? They recognized an opportunity and used it to their advantage.

   http://thehealthcareblog.com/blog/2016/01/19/is-health-care-ripe-for-disintermediation/

   That trend: disintermediation—the opportunity to deliver a product or service to a consumer with higher perceived value than an incumbent’s by changing the fundamental way it is delivered.

   Dr. David Marcinko MBA
   http://www.BusinessofMedicalPractice.com

   LikeLike
5. Editor, on April 26, 2018 at 8:41 PM said:

   Venture capitalists are paying attention to NY

   From the first annual New York City Healthcare Venture Capital Report 2018, lots of interesting data points:

   1.There are approximately 300 venture firms investing in healthcare with headquarters or dedicated offices in New York City.

   2.Overall the New York City VC industry remains fairly concentrated. With a hand in 25% of the deals in 2017, five firms that dominate are Orbimed, New Enterprise Associates, Venrock, Deerfield Management, and Canaan Partners.

   3.The top 30 VCs are involved in almost 60% of the deal volume.

   4.There are approximately 300 NYC-based healthcare companies that accounted for 510 deals between 2010 and 2017

   5. In 2017, 79 healthcare companies received $703 million in funding.

   Jay Dwivedi

   LikeLike
6. Dr. David E. Marcinko MBA, on August 14, 2020 at 1:39 AM said:

   PANDEMIC VENTURE CAPITAL and Physician Nurse Employment

   https://www.propublica.org/article/coronavirus-er-doctors-nurses-benefits?utm_sq=gfnmz64nrn&utm_source=linkedin&utm_medium=social&utm_campaign=carlcschuesslerjrdhpdiagbds&utm_content=articles

   Dr. David E. Marcinko MBA

   LikeLike
7. Editor-in-Chief, on March 28, 2022 at 7:19 PM said:

   Venture Capitalists in ERs

   Today, an estimated 40-plus percent of the nation’s hospital emergency departments are overseen by for-profit health care staffing companies owned by private-equity firms, academic research, regulatory filings and internal documents show. Two of the largest, according to their websites and news releases, are Envision Healthcare, owned by KKR, and TeamHealth, of the Blackstone Group. EmCare, the health care staffing company that managed Brovont, is part of Envision.

   Private-equity firms have taken over a broad swath of health care entities in recent years. They use large amounts of debt to acquire companies, aiming to increase their profits quickly so they can resell them at a gain in a few years.

   Any thoughts?

   Fredolin

   LikeLike
8. The D.E.A. ROGUE WARRIOR, on December 17, 2022 at 11:05 AM said:

   2022 Year End

   It may be the most wonderful time of the year but it’s also…Q4 layoff time. The latest: Goldman Sachs is planning to lay off as many as 4,000 employees, or roughly 8% of its workforce, Semafor reported yesterday.

   Goldman Sachs also plans to trim or fully cut some employees’ year-end bonuses—which on Wall Street are a lot more than a $50 gift card to Macaroni Grill. Getting no bonus is called being “zeroed out” and is considered a strong nudge to quit.

   Even so, Goldman Sachs’s workforce (currently 49,000) will remain bigger than it was before the pandemic (38,000). The bank hired aggressively in 2020 and 2021 while also suspending layoffs and buoying bonuses.

   Stewart

   LikeLike
9. Dr. Marcinko, on January 24, 2023 at 1:13 PM said:

   UPDATE

   Venture capitalists poured in nearly $22 billion in 2022, second only to the record $28 billion allocated in 2021, but that’ll likely dry up in 2023 as investments return to 2020 levels ($16.8 billion), according to a January report from SVB Financial Group, the parent of Silicon Valley Bank. (Not that we’re laughing at approximately $15 billion this year in anticipated VC fundraising for healthcare ventures—an area which has grown steadily over the last decade.)

   The report highlighted some areas to watch:

   Biopharma: Investment in the biopharma sector totaled $29.5 billion in 2022, down from $38.7 billion in 2021 despite a strong first quarter. It is expected to hover around 2020 levels ($27.4 billion in total) this year, but with increased funding in autoimmune and respiratory companies.

   Medical devices: The sector kept pace last year with the 2021 record investments (a total of $8.5 billion compared to $9.2 billion, respectively). Investment in 2023 is expected to largely mirror what we saw in 2020 ($6.6 billion), but we can expect fewer $100+ million deals, given fundraising for top companies in 2022.

   Medical diagnostics: Investment in medical diagnostics and tools companies is likely to rebound from the second half of 2022 and finish the year at $8 billion–$9 billion, just below the 2020 pace ($10.9 billion). Sector investment fell from a total of $14.7 billion in 2021 to $9.9 billion in 2022.

   DEM

   LikeLike